SZLSF (StageZero Life Sciences) Shiller PE Ratio: (As of Aug. 31, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SZLSF StageZero Life Sciences Ltd SZLSF
10 GF Score
Price $0.00
View Full Analysis

What is StageZero Life Sciences Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


StageZero Life Sciences  (OTCPK:SZLSF) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


StageZero Life Sciences Shiller PE Ratio Related Terms


StageZero Life Sciences Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for StageZero Life Sciences's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

StageZero Life Sciences Shiller PE Ratio Chart

StageZero Life Sciences Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

StageZero Life Sciences Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24 Jun24 Sep24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

SZLSF vs IDTA, TTOO, NSTM: Shiller PE Ratio Comparison

For the Diagnostics & Research subindustry, StageZero Life Sciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


StageZero Life Sciences Shiller PE Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, StageZero Life Sciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where StageZero Life Sciences's Shiller PE Ratio falls into.


SZLSF
10GF Score
StageZero Life Sciences Ltd SZLSF
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

StageZero Life Sciences Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

StageZero Life Sciences's E10 for the quarter that ended in Sep. 2024 is calculated as:

For example, StageZero Life Sciences's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-0.003/127.2847*127.2847
=-0.003

Current CPI (Sep. 2024) = 127.2847.

StageZero Life Sciences Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201409 -0.160 99.394 -0.205
201412 -0.320 98.367 -0.414
201503 -0.160 99.789 -0.204
201506 -0.240 100.500 -0.304
201509 -0.320 100.421 -0.406
201512 -0.160 99.947 -0.204
201603 -0.400 101.054 -0.504
201606 -0.160 102.002 -0.200
201609 -0.320 101.765 -0.400
201612 0.160 101.449 0.201
201703 -0.160 102.634 -0.198
201706 -0.080 103.029 -0.099
201709 -0.080 103.345 -0.099
201712 -0.026 103.345 -0.032
201803 -0.038 105.004 -0.046
201806 -0.160 105.557 -0.193
201809 -0.080 105.636 -0.096
201812 0.080 105.399 0.097
201903 -0.240 106.979 -0.286
201906 -0.026 107.690 -0.031
201909 0.080 107.611 0.095
201912 -0.017 107.769 -0.020
202003 -0.080 107.927 -0.094
202006 -0.010 108.401 -0.012
202009 -0.050 108.164 -0.059
202012 -0.025 108.559 -0.029
202103 -0.080 110.298 -0.092
202106 0.050 111.720 0.057
202109 -0.020 112.905 -0.023
202112 -0.050 113.774 -0.056
202203 -0.010 117.646 -0.011
202206 -0.010 120.806 -0.011
202209 0.000 120.648 0.000
202212 -0.090 120.964 -0.095
202303 -0.020 122.702 -0.021
202306 -0.003 124.203 -0.003
202309 -0.010 125.230 -0.010
202403 -0.003 126.258 -0.003
202406 -0.005 127.522 -0.005
202409 -0.003 127.285 -0.003

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


StageZero Life Sciences Business Description

Address 70 East Beaver Creek Road, Unit 30, Richmond Hill, ON, CAN, L4B 3B2
StageZero Life Sciences Ltd is a vertically integrated healthcare company at the nexus of three sectors of healthcare; Early Cancer Detection, Liquid Biopsy, and Global Telehealth. It is focused on minimizing the risk of cancer and other chronic diseases through early detection and intervention. It continues to develop and commercialize proprietary molecular diagnostic tests for the early detection of diseases and personalized health management, with a focus on cancer-related indications. It has developed a proprietary platform technology, the Sentinel Principle, to identify novel biomarkers from whole blood. The Company's lead product, Aristotle, is a blood-based molecular diagnostic assessment that can detect an individual's current risk for potentially having a variety of cancers.
10GF Score

Get the complete analysis for SZLSF

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price